Psoriasis trials in Hungary

In Hungary 9 Also abroad 274

9 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
Where
Budapest, Miskolc, Székesfehérvár, Veszprém
Age
18 years and over
People
300 worldwide
Run by
AbbVie
See details and how to joinNCT06865105
No phaseTaking people
A Study of Guselkumab Given After Ustekinumab in Participants With Moderate to Severe Psoriasis in Routine Clinical Practice
Where
Budapest
Age
18 years and over
People
100
Run by
Janssen-Cilag Kft.
See details and how to joinNCT07746583
Phase 3Taking people
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Where
Budapest, Budapest III, Debrecen, Orosháza, Szeged, Szolnok, Veszprém
Age
40 years and over
People
3,040 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07116967 · EU 2023-503766-24-00
Phase 3Taking people
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
Where
Budapest III, Debrecen, Szeged
Age
12 years to 17 years
People
366 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT06979453 · EU 2023-506296-97-00
Phase 3Taking people
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Where
Budapest, Hódmezővásárhely, Szeged, Szekesfehervar, Székesfehérvár, Veszprem
Age
18 years and over
People
1,088 worldwide
Run by
Takeda
See details and how to joinNCT06671483 · EU 2024-513111-27-00
Phase 3Taking people
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Where
Budapest, Hódmezővásárhely, Szeged, Szekesfehervar, Székesfehérvár, Veszprem
Age
18 years and over
People
1,182 worldwide
Run by
Takeda
See details and how to joinNCT07286058 · EU 2025-522586-30-00
Phase 3Taking people
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled and Deucravacitinib Active Comparator-controlled Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis
Where
Budapest III, Debrecen, Kaposvár, Pécs, Szeged, Szolnok, Veszprém
Age
18 years and over
People
320 worldwide
Run by
Janssen - Cilag International
See details and how to join2023-505121-14-00 · EU 2023-505121-14-00
No phaseTaking people
PALLAS Laser for Skin Diseases
Where
Szeged
Age
18 years to 65 years
People
50
Run by
Szeged University
See details and how to joinNCT07250997
No phaseTaking people
Novel Complex Radiodiagnostics of Peripherial Arthropathies
Where
Budapest
Age
18 years to 100 years
People
500
Run by
Semmelweis University
See details and how to joinNCT05657847